TCM
Tamarack Capital Management Portfolio holdings
AUM
$503M
1-Year Return
15.45%
This Quarter Return
+11.09%
1 Year Return
+15.45%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$245M
AUM Growth
+$74.5M
(+44%)
Cap. Flow
+$43.5M
Cap. Flow
% of AUM
17.74%
Top 10 Holdings %
Top 10 Hldgs %
59.67%
Holding
33
New
7
Increased
12
Reduced
9
Closed
2
Top Buys
| 1 |
Quest Diagnostics
DGX
|
$23.2M |
| 2 |
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
|
$9.1M |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
$8.3M |
| 4 |
Edwards Lifesciences
EW
|
$7.81M |
| 5 |
NTUS
Natus Medical Inc
NTUS
|
$6.21M |
Top Sells
| 1 |
Haemonetics
HAE
|
$9.3M |
| 2 |
Pacira BioSciences
PCRX
|
$8.36M |
| 3 |
AGN
ALLERGAN INC
AGN
|
$8M |
| 4 |
MDAS
MEDASSETS INC COM STK (DE)
MDAS
|
$3.59M |
| 5 |
Integer Holdings
ITGR
|
$3.06M |
Sector Composition
| 1 | Healthcare | 71.55% |
| 2 | Technology | 3.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GTIV
26
DELISTED
GENTIVA HEALTH SERVICES INC
GTIV
| $1.9M | 0.5% |
157,525
+22,978
| +17% | +$277K |
|
27
Standard BioTools
LAB
$477M
| $965K | 0.26% |
43,974
-100,428
| -70% | -$2.2M |
|
|
NXTM
28
DELISTED
NxStage Medical Inc.
NXTM
| $329K | 0.09% |
+25,000
| New | +$329K |
|
|
29
Haemonetics
HAE
$2.58B
| – | – |
-225,000
| Closed | -$9.3M |
|
30
SPDR S&P 500 ETF Trust
SPY
$658B
| – | – |
0
| – | – |
|
31
Teva Pharmaceuticals
TEVA
$21.3B
| – | – |
0
| – | – |
|
32
Health Care Select Sector SPDR Fund
XLV
$33.8B
| – | – |
0
| – | – |
|
|
AGN
33
DELISTED
ALLERGAN INC
AGN
| – | – |
-95,000
| Closed | -$8M |
|